Nexstim H1 FY26 net loss widens to EUR 861,900; net sales rise 16.1% to EUR 5.2 million

• Nexstim reported H1 net sales of EUR 5.2 million, up 16.1%, while the operating loss widened 29.8% to EUR 319,900.
• Net loss widened to EUR 861,900 from deeper financing-related one-off costs of EUR 600,000; EPS was EUR -0.12.
• EBITDA rose 9.8% to EUR 264,100, while cash and cash equivalents climbed to EUR 5.6 million.
• Licensing net sales more than doubled to EUR 800,000, while system sales fell 12.4% to EUR 1.9 million.
• Nexstim agreed a EUR 5 million investment with Eiffel Investment Group and Brainlab; it expects net sales to grow and operating result to improve in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexstim Oyj published the original content used to generate this news brief on August 14, 2026, and is solely responsible for the information contained therein.